- Report
- March 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3071EUR$3,240USD£2,566GBP
€3412EUR$3,600USD£2,851GBP
- Report
- November 2018
- 30 Pages
China
From €2085EUR$2,200USD£1,742GBP
- Report
- August 2023
- 201 Pages
Global
From €7109EUR$7,500USD£5,939GBP
- Report
- January 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Report
- February 2024
- 108 Pages
Global
From €3500EUR$3,956USD£3,026GBP
Acarbose is a drug used to treat endocrine and metabolic disorders. It is an alpha-glucosidase inhibitor, which works by slowing down the digestion of carbohydrates in the small intestine. This helps to reduce the amount of glucose absorbed into the bloodstream, which can help to control blood sugar levels in people with diabetes. Acarbose is also used to treat other conditions such as obesity and polycystic ovary syndrome.
Acarbose is available in both generic and branded forms, and is sold in tablet and capsule form. It is usually taken three times a day, before meals. Common side effects include abdominal pain, flatulence, and diarrhea.
The Acarbose market is highly competitive, with a number of companies offering products. Some of the major players in the market include Novo Nordisk, Sanofi, Merck, and Pfizer. Show Less Read more